ERBB2 and neoplasm: In 19 GCs (79 %), 19 GCs (79 %), and 15 GCs (63 %), the percentage of HER2-positive cells in either one or two biopsy specimens from the luminal oral, central, or anal region, respectively, was not significantly different from the percentage of HER2-positive cells in the whole tumor.